Cardiovascular
5 drugs are in development for Hypertension.
- Companies
- 5
- Clinical trials
- 81
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Hypertension pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Approved(2)
| Drug | Company |
|---|---|
| entresto | Novartis AG (NVS) |
| verapamil sr | Societal CDMO, Inc. (SCTL) |
Phase 3(1)
| Drug | Company |
|---|---|
| Ralinepag | UNITED THERAPEUTICS Corp (UTHR) |
Phase 2(1)
Unknown(1)
| Drug | Company |
|---|---|
| baxdrostat | CinCor Pharma, Inc. (CINC) |
About this indication
Hypertension context
Cardiovascular·MeSH: Hypertension (D006973)
Also known as: Blood Pressures, High, High Blood Pressure
Prevalence
47000.0 / 100K
Incidence
3000.0 / 100K/yr
Compare drugs
Frequently asked questions
How many drugs are in development for Hypertension?
BioSniper tracks 5 drugs in development for Hypertension across 5 companies.
How many clinical trials target Hypertension?
There are 81 clinical trials targeting Hypertension tracked by BioSniper.
What is the prevalence of Hypertension?
The estimated prevalence of Hypertension is approximately 47000.0 per 100,000 population.